ASX:PMEHealthcare Services
Pro Medicus (ASX:PME) Shares Valuation After S&P/ASX 50 Removal And Recent Contract Renewals
Pro Medicus (ASX:PME) is under focus after S&P Dow Jones decided to remove the stock from the S&P/ASX 50 Index, a technical shift that can influence trading by index-tracking funds.
See our latest analysis for Pro Medicus.
At around A$164.0, Pro Medicus has bounced with a 30.68% 1 month share price return and 23.31% 3 month share price return, yet its 1 year total shareholder return is down 39.14%. This means recent momentum contrasts with weaker long term results.
If this index reshuffle has...